The price charged by pharmaceutical companies in the USA is often much higher than what the same product is sold for in other countries.
US cost should be indexed to no more than 5% above the lowest price a manufacturer or distributor of pharmaceuticals is willing to charge for any particular drug in any other country.
This is similar to the Maximum Allowable Cost for drugs used for Medicaid prescriptions.